Stock Analiz

CVS HEALTH Corp (CVS) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

CVS HEALTH’s revenue went from $177.5B in fiscal 2016 to $402.1B in fiscal 2025, growth of about 9.5% a year.

Net income in fiscal 2025 was $1.8B, a net margin of 0.4%; the best year in this period was 2023 with $8.3B.

Over the twelve months to September 30, 2026, revenue was $420.6B and net income $11.0B.

Free cash flow was $7.8B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 18% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $177.5B162017: $184.8B172018: $194.6B182019: $256.8B192020: $268.7B202021: $292.1B212022: $322.5B222023: $357.8B232024: $372.8B242025: $402.1B25$402.1B
Net income
2016: $5.3B162017: $6.6B172018: -$594M182019: $6.6B192020: $7.2B202021: $8.0B212022: $4.3B222023: $8.3B232024: $4.6B242025: $1.8B25$1.8B
Free cash flow
2016: $7.9B162017: $6.1B172018: $6.8B182019: $10.4B192020: $13.4B202021: $15.7B212022: $13.4B222023: $10.4B232024: $6.3B242025: $7.8B25$7.8B
EPS (diluted)
2016: $4.90162017: $6.44172018: $-0.57182019: $5.08192020: $5.46202021: $6.02212022: $3.26222023: $6.47232024: $3.66242025: $1.3925$1.39

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$420.6B$402.1B$372.8B$357.8B$322.5B$292.1B$268.7B$256.8B$194.6B$184.8B$177.5B
Gross profit$186.1B$180.9B$166.5B$140.7B$125.6B$116.3B$104.7B$98.1B$38.1B$28.5B$28.9B
Operating income$15.1B$4.7B$8.5B$13.7B$8.0B$13.3B$13.9B$12.0B$4.0B$9.5B$10.4B
Net income$11.0B$1.8B$4.6B$8.3B$4.3B$8.0B$7.2B$6.6B-$594M$6.6B$5.3B
EPS (diluted)$8.61$1.39$3.66$6.47$3.26$6.02$5.46$5.08$-0.57$6.44$4.90
R&D———————————
Revenue growth—+7.8%+4.2%+10.9%+10.4%+8.7%+4.7%+32.0%+5.3%+4.1%+15.8%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$18.7B$10.6B$9.1B$13.4B$16.2B$18.3B$15.9B$12.8B$8.9B$8.0B$10.1B
Capital spending-$3.1B-$2.8B-$2.8B-$3.0B-$2.7B-$2.5B-$2.4B-$2.5B-$2.0B-$1.9B-$2.2B
Free cash flow$15.6B$7.8B$6.3B$10.4B$13.4B$15.7B$13.4B$10.4B$6.8B$6.1B$7.9B
Dividends paid$3.4B$3.4B$3.4B$3.1B$2.9B$2.6B$2.6B$2.6B$2.0B$2.0B$1.8B
Buybacks—$0$3.0B$2.0B$3.5B$0$0$0$0$4.4B$4.5B
Stock-based pay$745M$535M$540M$588M$447M$484M$400M$453M$280M$234M$222M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$10.6B$11.0B$11.5B$15.7B$12.5B$10.9B$8.1B$6.6B$1.8B$3.5B
Debt—$79.1B$79.9B$78.3B$70.8B$76.0B$85.0B$89.0B$75.5B$27.3B$25.7B
Equity—$75.2B$75.6B$76.5B$71.5B$75.1B$69.4B$63.9B$58.2B$37.7B$36.8B
Total assets—$253.5B$253.2B$249.7B$228.3B$233.0B$230.7B$222.4B$196.5B$95.1B$94.5B
Shares (diluted)1.29B1.27B1.26B1.29B1.32B1.33B1.31B1.30B1.04B1.02B1.08B

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin44.2%45.0%44.7%39.3%38.9%39.8%39.0%38.2%19.6%15.4%16.2%
Operating margin3.6%1.2%2.3%3.8%2.5%4.6%5.2%4.7%2.1%5.2%5.9%
Net margin2.6%0.4%1.2%2.3%1.3%2.7%2.7%2.6%-0.3%3.6%3.0%
FCF margin3.7%1.9%1.7%2.9%4.2%5.4%5.0%4.0%3.5%3.3%4.5%
ROIC—2.4%4.1%6.7%4.2%6.7%6.6%5.8%2.4%11.8%10.2%
ROE—2.4%6.1%10.9%6.0%10.7%10.3%10.4%-1.0%17.6%14.4%

Frequently asked questions

What is CVS HEALTH’s annual revenue?

$402.1B in fiscal 2025 and $420.6B over the twelve months to September 30, 2026.

How much profit does CVS HEALTH make?

Net income was $1.8B in fiscal 2025 (net margin 0.4%).

Is CVS HEALTH’s revenue growing?

Yes: revenue rose 7.8% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.